• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

个体化糖尿病护理:来自真实世界经验的教训。

Individualized diabetes care: Lessons from the real-world experience.

作者信息

Khor Xiao Ying, Pappachan Joseph M, Jeeyavudeen Mohammad Sadiq

机构信息

Department of Endocrinology and Metabolism, Lancashire Teaching Hospitals NHS Trust, Preston PR2 9UT, United Kingdom.

Faculty of Science, Manchester Metropolitan University, Manchester M15 6BH, United Kingdom.

出版信息

World J Clin Cases. 2023 May 6;11(13):2890-2902. doi: 10.12998/wjcc.v11.i13.2890.

DOI:10.12998/wjcc.v11.i13.2890
PMID:37215423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10198090/
Abstract

Diabetes care is often difficult without a proper collaboration between the patient and the care provider as the disease is mostly self-managed by patients through adjustments in their lifestyles, and medication doses to optimise glycaemic control. Most clinical guidelines on the management of diabetes mellitus (DM) provide only broad principles on diabetes care, and the blind follow-up of such principles without a proper review and consideration of patient characteristics often results in inadequate glycaemic control and diabetes complications consequently. Therefore, a proper understanding of the pathobiology, clinical situation, and comorbidities of the individual case is of paramount importance to tailoring the most appropriate management strategy in real-world diabetes care. With the aid of five unique cases of DM [(1) Medically managed type 2 diabetes mellitus (T2DM) with severe obesity; (2) Management of T2DM with unreliable glycated haemoglobin (HbA1c); (3) Obesity in a patient with type 1 diabetes mellitus (T1DM); and (4) Late diagnosis and subsequent management of monogenic diabetes and 5. Sudden worsening of well-controlled T2DM)] we elaborate on the importance of individualised diabetes care and the practicalities in these situations. The review also provides an evidence update on the management of different forms of DM to guide physicians in optimising the care of their patients in day-to-day clinical practice.

摘要

如果患者与医护人员之间没有适当的协作,糖尿病护理往往会很困难,因为这种疾病大多由患者通过调整生活方式和药物剂量来自我管理,以优化血糖控制。大多数糖尿病管理临床指南仅提供糖尿病护理的宽泛原则,盲目遵循这些原则而不适当审查和考虑患者特征,往往会导致血糖控制不佳,进而引发糖尿病并发症。因此,在现实世界的糖尿病护理中,正确了解个体病例的病理生物学、临床情况和合并症对于制定最合适的管理策略至关重要。借助五个独特的糖尿病病例((1) 药物治疗的重度肥胖2型糖尿病 (T2DM);(2) 糖化血红蛋白 (HbA1c) 不可靠的T2DM管理;(3) 1型糖尿病 (T1DM) 患者的肥胖症;(4) 单基因糖尿病的晚期诊断及后续管理;以及(5) 血糖控制良好的T2DM突然恶化),我们阐述了个体化糖尿病护理的重要性以及在这些情况下的实际操作。本综述还提供了不同类型糖尿病管理的证据更新,以指导医生在日常临床实践中优化对患者的护理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/f0c9c4eb98ce/WJCC-11-2890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/7e2be5030502/WJCC-11-2890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/5b2a29187b5b/WJCC-11-2890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/f0c9c4eb98ce/WJCC-11-2890-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/7e2be5030502/WJCC-11-2890-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/5b2a29187b5b/WJCC-11-2890-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac4e/10198090/f0c9c4eb98ce/WJCC-11-2890-g003.jpg

相似文献

1
Individualized diabetes care: Lessons from the real-world experience.个体化糖尿病护理:来自真实世界经验的教训。
World J Clin Cases. 2023 May 6;11(13):2890-2902. doi: 10.12998/wjcc.v11.i13.2890.
2
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.糖尿病患者控制血糖的牙周疾病治疗
Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3.
3
Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.对于新诊断的糖化血红蛋白(HbA1c)>9%的 2 型糖尿病患者,短期强化胰岛素治疗可能是首选。
J Diabetes. 2017 Oct;9(10):890-893. doi: 10.1111/1753-0407.12581. Epub 2017 Aug 22.
4
Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.改善 2 型糖尿病患者的血糖控制结果无需在药物治疗上花费更多:来自英国国家糖尿病审计的经验教训。
Diabetes Obes Metab. 2018 Jan;20(1):185-194. doi: 10.1111/dom.13067. Epub 2017 Sep 8.
5
Three-Year Glycaemic Control and Management in Patients with Type 2 Diabetes Initiating Second-Line Treatment in Japan: A Prospective Observational Study, J-DISCOVER.日本2型糖尿病患者启动二线治疗后的三年血糖控制与管理:一项前瞻性观察性研究,J-DISCOVER
Diabetes Ther. 2022 Feb;13(2):251-264. doi: 10.1007/s13300-021-01192-x. Epub 2021 Dec 28.
6
Glycaemic control among patients with type 2 diabetes mellitus in seven European countries: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study.七个欧洲国家2型糖尿病患者的血糖控制:糖尿病管理的真实生活有效性和护理模式(RECAP-DM)研究结果
Diabetes Obes Metab. 2008 Jun;10 Suppl 1:8-15. doi: 10.1111/j.1463-1326.2008.00881.x.
7
Efficacy and safety of carbohydrate counting versus other forms of dietary advice in patients with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised clinical trials.1 型糖尿病患者碳水化合物计数与其他饮食建议形式的疗效和安全性:随机临床试验的系统评价和荟萃分析。
J Hum Nutr Diet. 2022 Dec;35(6):1030-1042. doi: 10.1111/jhn.13017. Epub 2022 May 11.
8
The trials and tribulations of determining HbA targets for diabetes mellitus.确定糖尿病患者 HbA 目标值的艰难历程。
Nat Rev Endocrinol. 2020 Dec;16(12):717-730. doi: 10.1038/s41574-020-00425-6. Epub 2020 Oct 20.
9
Semaglutide for the management of diabesity: The real-world experience.司美格鲁肽用于治疗糖尿病肥胖症:真实世界经验
World J Methodol. 2024 Sep 20;14(3):91832. doi: 10.5662/wjm.v14.i3.91832.
10
Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial.引导式自主抉择——1型糖尿病年轻女性患者治疗中青少年组与标准治疗组的对比:一项多中心随机对照试验的研究方案
Trials. 2017 Nov 24;18(1):562. doi: 10.1186/s13063-017-2296-6.

引用本文的文献

1
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus.多酚姜黄素的多方面作用:聚焦2型糖尿病
Curr Diabetes Rev. 2025;21(8):e15733998313402. doi: 10.2174/0115733998313402240726080637.
2
Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience.钠-葡萄糖协同转运蛋白2抑制剂在2型糖尿病管理中的疗效比较:一项真实世界研究。
World J Diabetes. 2024 Mar 15;15(3):463-474. doi: 10.4239/wjd.v15.i3.463.
3
Diabesity and Dietary Interventions: Evaluating the Impact of Mediterranean Diet and Other Types of Diets on Obesity and Type 2 Diabetes Management.

本文引用的文献

1
Pharmacogenomics of GLP-1 receptor agonists: Focus on pharmacological profile.GLP-1 受体激动剂的药物基因组学:关注药理学特征。
Eur J Pharmacol. 2022 Dec 5;936:175356. doi: 10.1016/j.ejphar.2022.175356. Epub 2022 Oct 28.
2
Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta-analysis.肥胖成人中胰高血糖素样肽-1 受体激动剂与减重手术间的体重减轻:系统评价和荟萃分析。
Obesity (Silver Spring). 2022 Nov;30(11):2111-2121. doi: 10.1002/oby.23563.
3
Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).
糖尿病肥胖症与饮食干预:评估地中海饮食和其他类型饮食对肥胖症和 2 型糖尿病管理的影响。
Nutrients. 2023 Dec 21;16(1):34. doi: 10.3390/nu16010034.
精准糖尿病:从青少年起病的成年型糖尿病(MODY)中吸取的经验教训。
J Diabetes Investig. 2022 Sep;13(9):1465-1471. doi: 10.1111/jdi.13860. Epub 2022 Jun 16.
4
How do I diagnose Maturity Onset Diabetes of the Young in my patients?我如何诊断我的患者是否患有青年发病的成年型糖尿病?
Clin Endocrinol (Oxf). 2022 Oct;97(4):436-447. doi: 10.1111/cen.14744. Epub 2022 May 2.
5
Managing weight and glycaemic targets in people with type 2 diabetes-How far have we come?2型糖尿病患者的体重管理与血糖目标——我们取得了多大进展?
Endocrinol Diabetes Metab. 2022 May;5(3):e00330. doi: 10.1002/edm2.330. Epub 2022 Mar 17.
6
Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial.每周皮下司美格鲁肽与每日利拉鲁肽对无糖尿病超重或肥胖成年人体重的影响:STEP 8 随机临床试验。
JAMA. 2022 Jan 11;327(2):138-150. doi: 10.1001/jama.2021.23619.
7
Improving Palliative Care and Quality of Life in Pancreatic Cancer Patients.改善胰腺癌患者的姑息治疗和生活质量。
J Palliat Med. 2022 May;25(5):720-727. doi: 10.1089/jpm.2021.0187. Epub 2021 Oct 26.
8
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs.GLP-1 受体激动剂与 2 型糖尿病的心脏肾脏结局:八项心血管结局试验的更新荟萃分析。
Cardiovasc Diabetol. 2021 Sep 15;20(1):189. doi: 10.1186/s12933-021-01366-8.
9
Anti-diabetic drugs and weight loss in patients with type 2 diabetes.抗糖尿病药物与 2 型糖尿病患者的体重减轻。
Pharmacol Res. 2021 Sep;171:105782. doi: 10.1016/j.phrs.2021.105782. Epub 2021 Jul 22.
10
Obesity in Patients with Type 1 Diabetes: Links, Risks and Management Challenges.1型糖尿病患者的肥胖:关联、风险及管理挑战
Diabetes Metab Syndr Obes. 2021 Jun 21;14:2807-2827. doi: 10.2147/DMSO.S223618. eCollection 2021.